Financial Daily from THE HINDU group of publications
Saturday, Feb 01, 2003

News
Features
Stocks
Port Info
Archives

Group Sites

Corporate Results - Chemicals
Corporate - Financial Performance


Exports drive Jubilant net up 191 pc in Q3

Our Bureau

NEW DELHI, Jan. 31

SPECIALITY chemicals company Jubilant Organosys Ltd has reported 191 per cent increase in net profit to Rs 13.1 crore for the third quarter ended December 31, 2002, as against Rs 4.5 crore in the corresponding quarter last year.

Net sales recorded a growth of 36 per cent to Rs 194.1 crore compared to Rs 142.6 crore in the same quarter last year. And speciality chemicals, continuing its growth path, contributed the lion's share of 69 per cent in this quarter, compared to 57 percent in the comparable period.

Export revenue grew to Rs 51.3 crore, up 79 per cent over the previous year's Rs 28.6 crore.

Meanwhile, in the nine-month period (April-December), the company recorded a growth of 161 per cent in net profit to touch Rs 38.1 crore, compared to Rs 14.6 crore in the previous year. The net sales touched Rs 527.6 crore recording a growth of 20 per cent over Rs 440.4 crore recorded in the corresponding period last year. Exports revenue increased 82 per cent from Rs 75 crore to Rs 136.3 crore.

In its communiqué issued here on Friday, the company said that the active pharmaceutical ingredients (API) business acquired from Max India was integrated for the period of four months (September-December) and the results reflected this.

Subsequently, the last quarter's revenues included the performance of acquired API business of Rs 25.5 crore since as per the business transfer agreement signed with Max on November 20, the economic benefits accrue to the company with effect from September 1.

Mr Shyam S. Bhartia, Chairman, pointed out that, "While our business continues to gain strength, our exports and speciality chemicals performance has delivered exceptional results. With the financial integration of the API operations, our business model gains another dimension where the revenue contribution from the pharmaceuticals sector has shown a substantial increase."

Article E-Mail :: Comment :: Syndication

Stories in this Section
DCM Shriram


Exports drive Jubilant net up 191 pc in Q3
Bharat Electronics Q3 net up 106 pc
Retention price cut, poor demand hit MCF Q3 net
Higher sales drive Reliance profits — Our future is in oil, power, infocom: Anil Ambani
Higher output boosts ONGC net 84 pc
HPCL Q3 profit zooms
Sun Pharma net up 20 pc on higher sales
Aurobindo sales, net up in Q3
Raymond Q3 net up at Rs 19 cr
Precot Mills net up at 21 pc
Improved efficiencies boost Colgate net up 33 pc
Balaji Telefilms net up at 105 pc
Sundram Fasteners Q3 net up on higher sales
Kale Consultants net down
TVS-Electronics net dips
Infotech Enterprises Q3 revenues up; net slips
SSI net plunges to Rs 16 lakh
Drop in sales turnover hits TNPL net
Bank conversion expenses trim Kotak MFL net
Glaxo achieves zero debt status — Fourth quarter profit declines 33 pc
P&G's Q2 net up at Rs 32 cr
ICICI Bank net surges on retail focus — `Ahead of HDFC in home loan portfolio'
IOB's Q3 net up 157 pc


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright © 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line